We’re thrilled to share that Paul Bleicher, MD, PhD, a visionary in the field of #clinicaltrials technology, has joined YonaLink’s Advisory Board. Currently Executive Partner at @ArdanEquity, Dr. Bleicher has worn many hats in #LifeSciences & #healthcare.
https://t.co/mwv0xOWzhY
Over 50 percent of Americans feel awkward discussing finances, and many shy away from seeking help to cut costs. Ignoring this topic can lead to overspending, especially for trial sponsors.
It’s time to address the issue that everyone is thinking about
https://t.co/Gd72piwgy6
DIA may be winding down, but we'll never be finished talking about EHR-to-EDC streaming 😆
Come visit us at booth 1218!
#EHRtoEDC#ClinicalTrials#Innovation
Join us in just 2 hours for this important webinar about de-risking innovation in small pharma and biotech clinical research. We look forward to seeing you there!
https://t.co/oqBuwZ8jK7
#clinicaltrials#innovation
Mixii is just around the corner, and we're looking forward to joining hundreds of other amazing startups and hearing about the fantastic accomplishments that have taken place in health tech in the past year.
Will you be there? Let's meet up!
✔️ Florida in the winter
✔️ Great speakers
✔️ Old colleagues
✔️ New connections
We absolutely cannot wait for #SCOPE2024!
Let us know when you want to meet: https://t.co/QVjIJxuOe8
We want to hear from you!
What are the biggest data pain points you’ve encountered when working on a clinical trial?
What would make your data management experience easier?
Randomizing clinical trials is a challenge.
Yonalink lets setup admins assign subjects into treatment arms using block stratified or covariate adaptive randomization, without compromising blinding, making it easy to randomize trials of all sizes.
Groundbreaking medical treatments, including heparin, insulin, and ether anesthesia, were discovered by med students. This shouldn't be surprising - some truly innovative tech is being developed by Yonalink staffers who are pursuing advanced degrees while working.
Cervical cancer is the 4th-leading cause of cancer death in women. This #cervicalcancerawarenessmonth, let's recognize that cervical cancer rates in women aged 20-24 decreased by 65% from 2012-2019, due to the HPV vaccine and better education. Let's keep improving!
"November is #MensHealthMonth! Let's use this month to raise awareness about men's health issues such as prostate cancer, testicular cancer, and men's mental health challenges. Early detection and conversations saves lives. Schedule your annual checkups now. #Movember#menshealth
It's no wonder that EHR-to-EDC streaming has been impossible until now!
Yonalink has solved this problem by creating the first EHR-agnostic streaming system that can retreive and organize data from any EHR.
Want to see how Yonalink works? Contact us!
https://t.co/2iJNFgUkD3
From 2013 to 2022, the FDA's Center for Drug Evaluation and Research (CDER) averaged 43 drug approvals per year.
EHR-to-EDC streaming can help increase these numbers in the coming years by providing better quality data with improved oversight.
Learn more - https://t.co/2iJNFgUkD3
October is Breast Cancer Awareness Month - time to recognize that many breast cancer patients remain excluded from clinical trials, largely due to geographic barriers or restrictive trial criteria.
It's time to change design more inclusive trials.
#breastcancer#clinicaltrials
Is your site burned out by outdated EDCs, too much manual data entry, and balancing multiple platforms? All of these problems can be solved with Yonalink.
Want to hear more? Meet us at SCRS!
Boston...not just the home of the Red Sox and the marathon...it's also the home of Yonalink! Will you be joining us in Boston next week? Let us know, and let's meet up!